cytarabine has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (7.50) | 29.6817 |
| 2010's | 31 (77.50) | 24.3611 |
| 2020's | 6 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, S; Tang, Y; Zhao, L; Zhao, Y | 1 |
| Jabbour, EJ; Kadia, TM; Kantarjian, HM; Rausch, CR | 1 |
| Jin, J; Li, J; Yu, W; Zhang, X | 1 |
| Cao, LH; Chen, Y; Chen, YB; Du, J; Hu, J; Hu, X; Huang, X; Jin, J; Li, X; Lou, YJ; Mao, L; Qian, JJ; Qian, WB; Tao Meng, H; Tong, H; Wang, L; Wang, Y; Wei, J; Yan Yan, X; Yang, M; You, LS; Yu, W; Zhang, SJ; Zhang, Y; Zhao, JZ; Zhu, HH | 1 |
| Aberuyi, N; Ghaedi, K; Pourabutaleb, E; Rahgozar, S | 1 |
| Hosono, N; Ida, N; Kuze, A; Negoro, E; Yamauchi, T | 1 |
| Fosmire, SP; Garcia, TB; Porter, CC | 1 |
| Nancy, NK; Rajkumar, T; Sagar, TG; Valliyammai, N | 1 |
| Capello, E; Guolo, F; Lapucci, C; Mavilio, N; Roccatagliata, L; Romano, N | 1 |
| Wang, XX; Wu, D; Zhang, L | 1 |
| Penning, TM; Trippier, PC; Verma, K; Zang, T | 1 |
| Geerlinks, A; Hitzler, J; Keis, J; Ngan, B; Shammas, A; Vali, R | 1 |
| Droit, A; Fraszczak, J; Joly-Beauparlant, C; Kosan, C; Möröy, T; Rashkovan, M; Ross, J; Vadnais, C; Winkler, R | 1 |
| Akahane, D; Azuma, K; Katagiri, S; Ohyashiki, K; Saito, K | 1 |
| Eckert, C; Henze, G; v Stackelberg, A | 1 |
| Karawajew, L; Ludwig, WD; Möricke, A; Ratei, R; Schabath, R; Schrappe, M; Zimmermann, M | 1 |
| Escherich, G; Hagel, C; Hartz, B; Löbel, U | 1 |
| Guglin, M; Haq, M; Patel, A | 1 |
| Anderson, NM; Bradner, JE; Feng, H; Harrold, I; Lan Zhang, G; Look, AT; Mansour, MR; McKeown, M; Nagykary, N; Sanda, T | 1 |
| Chung, NG; Jang, W; Kim, M; Lee, JW | 1 |
| Baldus, CD; Bock, J; Hofmann, WK; Kühl, AA; Mochmann, LH; Neumann, M; Nowak, V; Ortiz-Tanchez, J; von der Heide, EK | 1 |
| Behulova, D; Bernatikova, H; Chocholova, A; Demlova, R; Mikuskova, A; Mladosievicova, B; Mrkvicova, M; Pilatova, K; Soltysova, A; Stary, J; Sterba, J; Sukova, M; Valik, D; Zdrazilova-Dubska, L | 1 |
| Baytan, B; Bengoa, SY; Evim, MS; Gözmen, S; Güneş, AM; Irken, G; Karapınar, TH; Oren, H; Tüfekçi, O | 1 |
| Akagi, T; Hofmann, WK; Jann, JC; Kato, M; Kawamata, N; Klaumünzer, M; Koeffler, HP; Liem, NL; Lock, RB; Marshall, GM; Mossner, M; Nowak, D; Nowak, V; Ogawa, S; Okamoto, R; Papa, RA; Sanada, M; Thoennissen, NH | 1 |
| Deng, L; Lin, N; Liu, W; Ping, L; Song, Y; Tu, M; Wang, X; Xie, Y; Ying, Z; Zhang, C; Zhang, Y; Zheng, W; Zhu, J | 1 |
| Baturin, D; Burleson, TM; Ford, JB; Kim, YM; Porter, CC; Van Linden, AA | 1 |
| Aref, S; El Menshawy, N; El-Baiomy, MA; El-Ghonemy, MS; Zeid, TA | 1 |
| Carrión Campo, R; Martínez Rubio, M; Moya Moya, MA; Rico Sergado, L; Saldaña Garrido, JD | 1 |
| Beverloo, HB; Cornelissen, JJ; Deenik, W; Valk, PJ; van der Poel-van de Luytgaarde, SC; van Esser, JW; Wattel, MM | 1 |
| Dai, L; Sun, AN; Wu, DP; Wu, YL; Xue, SL | 1 |
| Brown, AW; McGregor, BA; Osswald, MB; Savona, MR | 1 |
| Cai, Y; Ling, JY; Sun, XF; Xia, Y; Yan, SL; Zhen, ZJ | 1 |
| Cole, J; Hernandez, CP; Lopez-Barcons, LA; Morrow, K; Rodriguez, PC; Sierra, R; Velasco, C; Zabaleta, J | 1 |
| Fadoo, Z; Naqvi, A | 1 |
| Ciofani, T; Fan, M; Harasym, TO; Huang, R; Lim, WS; Mayer, LD; Tardi, PG; Xie, X | 1 |
| Bergmans, B; Deeren, D; Lammertijn, L; Lunskens, S; Maertens, J; Vandenberghe, R | 1 |
| Carter, KW; Cole, C; Firth, MJ; Ford, J; Gottardo, NG; Kees, UR; O'Leary, RA; Tesfai, Y | 1 |
| Attarbaschi, A; Beier, R; Lauten, M; Meissner, B; Möricke, A; Niemeyer, C; Niggli, F; Odenwald, E; Riehm, H; Schrappe, M; Stanulla, M; Zimmermann, M | 1 |
| Dahlhaus, M; Fischer, K; Freund, M; Glass, A; Junghanss, C; Lange, S; Schult, C | 1 |
| Ayed, S; Bouguila, H; Bouladi, M; Chebbi, A; Nacef, L; Taamallah-Malek, I | 1 |
3 review(s) available for cytarabine and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review.
Topics: Aclarubicin; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cells, T-Lymphoid; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2023 |
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
Topics: Adenine Nucleotides; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Etoposide; Fatal Outcome; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Male; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction; Reoperation; Salvage Therapy; Vidarabine; Vincristine; Young Adult | 2009 |
[Massive bilateral subconjunctival hemorrhage revealing acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Emergencies; Eye Hemorrhage; Fever; Gingival Hemorrhage; Humans; Male; Methotrexate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Purpura; Young Adult | 2013 |
2 trial(s) available for cytarabine and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Lineage; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Flow Cytometry; Humans; Immunophenotyping; Infant; Leukemia, Biphenotypic, Acute; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Analysis; Vincristine | 2013 |
Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Lymphocyte Count; Male; Mercaptopurine; Neoplasm, Residual; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Prospective Studies; Remission Induction; Risk Assessment; Treatment Outcome; Vincristine | 2012 |
35 other study(ies) available for cytarabine and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Constipation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Monitoring; Fusion Proteins, bcr-abl; Genetic Predisposition to Disease; Humans; Injections, Spinal; Intercellular Signaling Peptides and Proteins; Kidney; Methotrexate; Ophthalmic Solutions; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protein-Tyrosine Kinases; Vincristine | 2020 |
Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen.
Topics: Aclarubicin; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Combined Modality Therapy; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Homoharringtonine; Humans; Male; Mutation; Neoplasm Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Sulfonamides | 2020 |
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study.
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Young Adult | 2020 |
Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Topics: ATP-Binding Cassette Transporters; Child; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Leukemic; Humans; Methotrexate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Tumor Cells, Cultured; Vincristine | 2021 |
[Lineage switch from T-lymphoblastic leukemia to myeloid leukemia at relapse].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2021 |
Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cytarabine; DNA Damage; Drug Resistance, Neoplasm; Humans; Nuclear Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones | 2018 |
Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; DNA Mutational Analysis; F-Box-WD Repeat-Containing Protein 7; Female; Gene Expression Regulation, Neoplastic; Humans; India; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Mutation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Receptor, Notch1; Survival Analysis; Vincristine; Young Adult | 2018 |
Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Brain Diseases; Cytarabine; Humans; Injections, Spinal; Male; Methotrexate; Middle Aged; Myelitis, Transverse; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; White Matter | 2018 |
Clinical and molecular characterization of early T-cell precursor acute lymphoblastic leukemia: Two cases report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Female; Flow Cytometry; Humans; Male; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2018 |
Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Daunorubicin; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Structure-Activity Relationship | 2019 |
Unusual lymphoid malignancy and treatment response in two children with Down syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Down Syndrome; Herpesvirus 4, Human; Humans; Male; Methotrexate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes | 2019 |
Deletion of the Miz-1 POZ Domain Increases Efficacy of Cytarabine Treatment in T- and B-ALL/Lymphoma Mouse Models.
Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Mice, Transgenic; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Domains; Protein Inhibitors of Activated STAT; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases | 2019 |
A unique breast involvement detected by MRI-DWIBS in T cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Examination; Breast Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Doxorubicin; Drug Monitoring; Female; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Vincristine; Whole Body Imaging | 2019 |
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Europe; Hematopoietic Stem Cell Transplantation; Humans; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retreatment; Survival Rate; Vincristine | 2013 |
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Cerebellum; Child; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Guillain-Barre Syndrome; Humans; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methotrexate; Necrosis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Seizures; Spinal Cord | 2013 |
Cardiac lymphoma: sinus pauses disappear after chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Cisplatin; Cytarabine; Etoposide; Female; Humans; Methylprednisolone; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sick Sinus Syndrome | 2014 |
BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Differentiation; Cell Line, Tumor; Cytarabine; Drug Synergism; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Sulfonamides | 2014 |
Acute myeloid leukemia of mixed megakaryocytic and erythroid origin following chemotherapy for T-cell lymphoblastic lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Dexamethasone; Erythroid Cells; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Megakaryocytes; Mitoxantrone; Neoplasms, Second Primary; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine | 2014 |
ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cytarabine; Dasatinib; DNA Repair; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; K562 Cells; Mesoderm; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Signal Transduction; Thiazoles; Trans-Activators; Transcriptional Regulator ERG | 2014 |
Augmenting clinical interpretability of thiopurine methyltransferase laboratory evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromatography, High Pressure Liquid; Cyclophosphamide; Cytarabine; Czech Republic; Daunorubicin; Erythrocyte Membrane; Female; Genetic Association Studies; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Methyltransferases; Polymerase Chain Reaction; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Slovakia; Vincristine | 2014 |
The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Evaluation; Follow-Up Studies; Humans; Immunophenotyping; Infant; Kaplan-Meier Estimate; Leukocyte Count; Mercaptopurine; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Turkey; Vincristine | 2014 |
Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Topics: Animals; Antineoplastic Agents; Biopsy; Clone Cells; Cytarabine; Deoxycytidine Kinase; Dexamethasone; Disease Progression; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Gene Dosage; Heterografts; Humans; Male; Methotrexate; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Neoplasm Proteins; Neoplasm Transplantation; Neoplastic Stem Cells; Peptide Synthases; Polymorphism, Single Nucleotide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Radiation Chimera; Sequence Analysis, DNA; Vincristine | 2015 |
Outcomes of dose-adjusted Berlin-Frankfurt-Münster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Middle Aged; Neoplasm Staging; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2015 |
AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cytarabine; DNA Repair; Drug Synergism; Female; Flow Cytometry; Humans; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Pyrimidinones; Xenograft Model Antitumor Assays | 2015 |
Clinicopathologic Effect of DNMT3A Mutation in Adult T-Cell Acute Lymphoblastic Leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Egypt; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Mutation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Sequence Analysis, DNA; Young Adult | 2016 |
Leukaemic infiltration and cytomegalovirus retinitis in a patient with acute T-cell lymphoblastic leukaemia in complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Cytomegalovirus Retinitis; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemic Infiltration; Papilledema; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retina; Retinal Hemorrhage; Vidarabine | 2017 |
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Dasatinib; Daunorubicin; Granulocyte Colony-Stimulating Factor; Humans; In Situ Hybridization, Fluorescence; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neutropenia; Oncogene Proteins, Fusion; Peripheral Blood Stem Cell Transplantation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Splenic Rupture; Thiazoles; Vincristine; Young Adult | 2009 |
[Mechanism of CAG regimen eliminating T-cell acute lymphoblastic leukemia A3 cell line].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytarabine; Granulocyte Colony-Stimulating Factor; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Antigens, CD7; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclin D3; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Remission Induction; Survival Rate; Transcription Factors; Vincristine; Young Adult | 2010 |
Pegylated arginase I: a potential therapeutic approach in T-ALL.
Topics: Adult; Animals; Antineoplastic Agents; Arginase; Arginine; Cell Cycle; Cell Line, Tumor; Cyclin D3; Cytarabine; Disease-Free Survival; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Polyethylene Glycols; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Xenograft Model Antitumor Assays | 2010 |
Inadvertent intrathecal injection of PEG-asparaginase.
Topics: Antineoplastic Agents; Asparaginase; Child; Cytarabine; Delayed-Action Preparations; Humans; Injections, Spinal; Male; Medication Errors; Polyethylene Glycols; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2010 |
Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Chemistry, Pharmaceutical; Cytarabine; Daunorubicin; DNA-Binding Proteins; Dosage Forms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Flow Cytometry; Humans; Liposomes; Maximum Tolerated Dose; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Intracranial hypertension following intrathecal administration of liposomal cytarabine.
Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Humans; Injections, Spinal; Intracranial Hypertension; Liposomes; Magnetic Resonance Imaging; Male; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2011 |
Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Topics: Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Asparaginase; Biomarkers, Tumor; Bone Marrow Cells; Case-Control Studies; Cell Communication; Cell Survival; Cells, Cultured; Child; Cohort Studies; Cytarabine; Dexamethasone; Gene Expression Profiling; Humans; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Principal Component Analysis; Prognosis; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stromal Cells; Vincristine | 2012 |
The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Cell Growth Processes; Cell Line, Tumor; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Jurkat Cells; Leukemia, B-Cell; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |